American Research Corporation at the Texas Liver Institute — San Antonio, Texas

American Research Corporation at the Texas Liver Institute is a clinical research site located in San Antonio, Texas, United States 78215.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

American Research Corporation at the Texas Liver Institute has participated in 32 clinical trials with 6 currently active.

Therapeutic areas: Metabolic Dysfunction Associated Steatohepatitis, Non-alcoholic Steatohepatitis, Primary Biliary Cholangitis.

Sponsors: Boehringer Ingelheim, Novo Nordisk A/S, Intercept Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for American Research Corporation at the Texas Liver Institute?

American Research Corporation at the Texas Liver Institute has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has American Research Corporation at the Texas Liver Institute conducted?

American Research Corporation at the Texas Liver Institute has 32 clinical trials on record, with 6 currently active. Their work covers Metabolic Dysfunction Associated Steatohepatitis, Non-alcoholic Steatohepatitis, Primary Biliary Cholangitis.

Is American Research Corporation at the Texas Liver Institute accredited by Crixeo Health?

Yes — American Research Corporation at the Texas Liver Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about American Research Corporation at the Texas Liver Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.